Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Monlunabant

Study of INV-202 in Patients With Obesity and Metabolic Syndrome

Inversago Pharma · Phase 2 · Completed · Enrollment 243

NCT05891834

ArmPopulationDoseWeeksEstimandWeight change
Low doseObesity or overweightn/rn/rn/rn/r
High doseObesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r
Middle DoseObesity or overweightn/rn/rn/rn/r